Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma
Authors:
Open Access
- 25 June 2013
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 134 (1) , 65-71
Abstract
Human papillomavirus (HPV) has been implicated in multiple cancers, but its significance in lung cancer has remained controversial. As the prevalence of HPV 16/18 infection was higher in lung adenocarcinoma among Taiwanese females, the aim of our study was to evaluate the clinical impact of HPV infections in lung adenocarcinoma. Two hundred and ten patients were enrolled to investigate the associations of HPV status in tumors with clinical characteristics as well as its impact on overall survival. The methods to assess HPV status were by immunohistochemistry for HPV L1 capsid protein and E6 protein and by nested polymerase chain reaction for HPV 16 and HPV 18. HPV infections were identified in 35.2% of patients, and associated with localized and smaller sized tumors (p = 0.022 and p = 0.002, respectively). Patients with HPV infections had a significantly better survival (p = 0.023, by log‐rank test) and a significantly reduced mortality risk after adjustments of age, tumor extent, epidermal growth factor receptor (EGFR) mutations status and treatments [adjusted hazard ratio = 0.68, 95% confidence interval (CI) = 0.49–0.96, p = 0.026, by multivariate Cox proportional hazards models]. Specifically, patients with both HPV infections and EGFR mutations had the best survival outcome [1‐year survival rate, 68.5% (95% CI = 52.2–4.8%)]. Our findings indicate that HPV infections represent an independent prognostic factor for overall survival in patients with lung adenocarcinoma.Keywords
This publication has 29 references indexed in Scilit:
- EGFR mutations and human papillomavirus in lung cancerLung Cancer, 2012
- Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trialAnnals of Oncology, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Cellular Responses to Cisplatin‐Induced DNA DamageJournal of Nucleic Acids, 2010
- DNA Damage, Mutagenesis, and DNA RepairJournal of Nucleic Acids, 2010
- Nonsmall cell lung cancer in never smokersCurrent Opinion in Oncology, 2009
- Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenonHead & Neck, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2001